Analyze Diet
Veterinary immunology and immunopathology2015; 167(3-4); 122-129; doi: 10.1016/j.vetimm.2015.07.015

Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells.

Abstract: Equine herpesvirus-1 (EHV-1) is one of the most common and important respiratory viral pathogens of horses. EHV-1 in horses replicates initially in the respiratory epithelium and then spreads systematically to endothelial cells lining the small blood vessels in the uterus and spinal cord, and highly pathogenic virus strains can produce aborted fetuses or myeloencephalopathy. Like other herpes viruses, EHV-1 employs a variety of mechanisms for immune evasion. Some herpes viruses down-regulate the type-I interferon (IFN) response to infection, but such activity has not been described for EHV-1. Here, in an in vitro system utilizing an established equine endothelial cell line, we studied the temporal effect on IFN-β responses following infection with the neuropathogenic T953 strain of EHV-1. Results show that after an early induction of IFN-β, the virus actively shut down further production of IFN-β and this was correlated with expression of the viral late genes. Expression of the IFN response factor viperin, a marker of host cell type-I IFN responses, was also suppressed by T953 virus infection. EHV-1-mediated suppression of host type-I IFN responses may play an important role in EHV-1 pathogenesis and the mechanism of this, presumably involving a viral late gene product, warrants investigation.
Publication Date: 2015-08-05 PubMed ID: 26275803DOI: 10.1016/j.vetimm.2015.07.015Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates how Equine herpesvirus-1 (EHV-1), a common virus in horses, suppresses the immune response in endothelial cells, potentially furthering its own pathogenesis and warranting further study.

Introduction to the Research

  • The study is centered around Equine herpesvirus-1 (EHV-1), a major respiratory viral pathogen in horses. The virus first replicates in the respiratory epithelium of horses and then systematically spreads to endothelial cells – those lining the small blood vessels of the uterus and spinal cord.
  • Severe strains of EHV-1 can lead to aborted fetuses or myeloencephalopathy, a neurologic disorder.
  • Notably, EHV-1 uses several strategies to evade the immune response, just like other herpes viruses.

Main Findings

  • The research asserts that some herpes viruses are known to down-regulate the type-I interferon (IFN) response to infection; however, this characteristic hadn’t been previously observed concerning EHV-1.
  • Through an in-vitro experiment using an established equine endothelial cell line, the researchers studied the effects on IFN-β responses after infection with the neuropathogenic T953 strain of EHV-1.
  • Results indicated that although an early induction of IFN-β is observed, the virus eventually suppresses further production of IFN-β, correlating with an expression of the viral late genes.
  • Viral infection by T953 also results in the suppression of the IFN response factor ‘viperin’, a known marker of host cell type-I IFN responses.

Possible Implications and Future Research

  • The study suggests that the EHV-1’s suppression of type-I IFN responses could play a significant role in its pathogenesis.
  • This implies a viral late gene product probably drives the suppression mechanism, warranting further research to understand the implications better and potentially develop effective treatments.
  • These findings could further the understanding of herpes viruses’ modus operandi, potentially aiding in the prevention and treatment of other similar diseases.

Cite This Article

APA
Sarkar S, Balasuriya UB, Horohov DW, Chambers TM. (2015). Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells. Vet Immunol Immunopathol, 167(3-4), 122-129. https://doi.org/10.1016/j.vetimm.2015.07.015

Publication

ISSN: 1873-2534
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 167
Issue: 3-4
Pages: 122-129
PII: S0165-2427(15)00172-5

Researcher Affiliations

Sarkar, Sanjay
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546-0099, USA. Electronic address: sanjaysarkarvet@gmail.com.
Balasuriya, Udeni B R
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546-0099, USA.
Horohov, David W
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546-0099, USA.
Chambers, Thomas M
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546-0099, USA.

MeSH Terms

  • Animals
  • Cells, Cultured
  • Endothelial Cells / immunology
  • Gene Expression
  • Genes, Viral
  • Herpesviridae Infections / genetics
  • Herpesviridae Infections / immunology
  • Herpesviridae Infections / veterinary
  • Herpesvirus 1, Equid / genetics
  • Herpesvirus 1, Equid / immunology
  • Herpesvirus 1, Equid / pathogenicity
  • Horse Diseases / genetics
  • Horse Diseases / immunology
  • Horses
  • Interferon Type I / biosynthesis
  • Interferon Type I / genetics
  • Interferon-beta / biosynthesis
  • Interferon-beta / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Respiratory Mucosa / immunology

Citations

This article has been cited 10 times.
  1. Laval K, Poelaert KCK, Van Cleemput J, Zhao J, Vandekerckhove AP, Gryspeerdt AC, Garré B, van der Meulen K, Baghi HB, Dubale HN, Zarak I, Van Crombrugge E, Nauwynck HJ. The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1. Front Microbiol 2021;12:662686.
    doi: 10.3389/fmicb.2021.662686pubmed: 33746936google scholar: lookup
  2. Zarski LM, Weber PSD, Lee Y, Soboll Hussey G. Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection. Pathogens 2021 Jan 7;10(1).
    doi: 10.3390/pathogens10010043pubmed: 33430330google scholar: lookup
  3. Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry. Front Microbiol 2019;10:2668.
    doi: 10.3389/fmicb.2019.02668pubmed: 31849857google scholar: lookup
  4. Oladunni FS, Sarkar S, Reedy S, Balasuriya UBR, Horohov DW, Chambers TM. Equid Herpesvirus 1 Targets the Sensitization and Induction Steps To Inhibit the Type I Interferon Response in Equine Endothelial Cells. J Virol 2019 Dec 1;93(23).
    doi: 10.1128/JVI.01342-19pubmed: 31511388google scholar: lookup
  5. Poelaert KCK, Van Cleemput J, Laval K, Favoreel HW, Soboll Hussey G, Maes RK, Nauwynck HJ. Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense. Front Cell Infect Microbiol 2018;8:312.
    doi: 10.3389/fcimb.2018.00312pubmed: 30258819google scholar: lookup
  6. Hue ES, Richard EA, Fortier CI, Fortier GD, Paillot R, Raue R, Pronost SL. Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment. Vaccines (Basel) 2017 Sep 19;5(3).
    doi: 10.3390/vaccines5030028pubmed: 28925977google scholar: lookup
  7. Sobhy H. A Review of Functional Motifs Utilized by Viruses. Proteomes 2016 Jan 21;4(1).
    doi: 10.3390/proteomes4010003pubmed: 28248213google scholar: lookup
  8. Sarkar S, Bailey E, Go YY, Cook RF, Kalbfleisch T, Eberth J, Chelvarajan RL, Shuck KM, Artiushin S, Timoney PJ, Balasuriya UB. Allelic Variation in CXCL16 Determines CD3+ T Lymphocyte Susceptibility to Equine Arteritis Virus Infection and Establishment of Long-Term Carrier State in the Stallion. PLoS Genet 2016 Dec;12(12):e1006467.
    doi: 10.1371/journal.pgen.1006467pubmed: 27930647google scholar: lookup
  9. Sarkar S, Chelvarajan L, Go YY, Cook F, Artiushin S, Mondal S, Anderson K, Eberth J, Timoney PJ, Kalbfleisch TS, Bailey E, Balasuriya UB. Equine Arteritis Virus Uses Equine CXCL16 as an Entry Receptor. J Virol 2016 Jan 13;90(7):3366-84.
    doi: 10.1128/JVI.02455-15pubmed: 26764004google scholar: lookup
  10. Giessler KS, Goehring LS, Jacob SI, Davis A, Esser MM, Lee Y, Zarski LM, Weber PSD, Hussey GS. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses. J Gen Virol 2024 May;105(5).
    doi: 10.1099/jgv.0.001987pubmed: 38767608google scholar: lookup